Stay updated on Pembrolizumab for Pediatric Hodgkin Lymphoma Clinical Trial
Sign up to get notified when there's something new on the Pembrolizumab for Pediatric Hodgkin Lymphoma Clinical Trial page.

Latest updates to the Pembrolizumab for Pediatric Hodgkin Lymphoma Clinical Trial page
- Check2 days agoChange DetectedTwo NIH grant entries for 2017 and 2023 were added to the study record, indicating additional U.S. NIH funding support for this trial. This updates the funding context for readers reviewing the study's support sources.SummaryDifference0.1%

- Check9 days agoNo Change Detected
- Check16 days agoChange DetectedThe page revision version was updated from v3.6.4 to v3.6.5, signaling a small update to the page's content or metadata.SummaryDifference0.0%

- Check24 days agoChange DetectedThe Plain Language Summary has been removed from the Study Details page, eliminating the lay-friendly overview of the trial’s purpose and design. This shifts the page toward more technical content and may affect how easily non-specialists can understand the study.SummaryDifference0.0%

- Check31 days agoChange DetectedThe page's revision label was updated from v3.6.3 to v3.6.4. This reflects a minor internal update with no visible changes to study content or user-facing features.SummaryDifference0.0%

- Check52 days agoChange DetectedRevision: v3.6.3 was added and Revision: v3.6.2 was removed. This reflects a minor update to the study record's version metadata.SummaryDifference0.0%

- Check60 days agoChange DetectedThe page's revision tag was updated from v3.6.0 to v3.6.2, indicating a minor update to the document's metadata.SummaryDifference0.0%

Stay in the know with updates to Pembrolizumab for Pediatric Hodgkin Lymphoma Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Pembrolizumab for Pediatric Hodgkin Lymphoma Clinical Trial page.